Latest Post

(Having it) Made in China: The Chinese CRO market

(Having it) Made in China: The Chinese CRO market

When entering China, test your drugs as the Chinese do. That may not be as catchy as the saying about Romans, but it’s a rule that every company follows if they want to enter China’s pharmaceutical market, soon to be the second-largest globally. China is now home to dozens of R&D campuses established by global … Continue reading

Recent Posts


Enter your email address to follow this blog and receive notifications of new posts by email.

Download extract from IHS Flexible Pricing strategies multi client study
Drug Price Erosion Multi Client Study extract download

About This Blog

In this blog, our experts share regular insights on the global life sciences industry. Join us as we look at issues in healthcare policy, market access, pricing and reimbursement and R&D. Comments are welcome!
40 countries covered. Download a sample chapter on Brazil
Download a complimentary white paper on market-access risk ratings
Download a sample of the primary research and analysis on French P&R reform

Follow IHS Life Sciences on Twitter


Get every new post delivered to your Inbox.

Join 286 other followers